🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this trial is to improve the overall survival rate...
Status
Recruiting
Location
Subang Jaya Medical Centre
Start Date
2020-03-04
Trial ID
NCT06336395
Azacitidine can reverse clinical resistance to docetaxel through upregulati...
Status
Terminated
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2007-05
Trial ID
NCT00503984
RATIONALE: Pentostatin may stop the growth of cancer cells by blocking some...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2005-07
Trial ID
NCT00546377
A phase Ib partially blinded pilot study to evaluate the safety and immunol...
Status
Completed
Location
University of Pennsylvania. Clinical Trials Unit
Start Date
2008-09
Trial ID
NCT00775424
Treatments Being Tested
This is a Phase II/III, randomized, multicenter, open-label clinical trial ...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-08-04
Trial ID
NCT05980481
Epilepsy is one of common serious neurological malfunction, characterized b...
Status
Unknown
Location
Multiple Locations
Start Date
2020-02-01
Trial ID
NCT04219930
Treatments Being Tested
Background: Previously we have demonstrated induction of tumor antigen and...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2002-05-17
Trial ID
NCT00037817
Treatments Being Tested
RATIONALE: Studying samples of blood and tumor tissue from patients with ca...
Status
Terminated
Location
Unversity of Nebraska Medical Center
Start Date
2004-04-15
Trial ID
NCT00665457
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy and total-body irradiation befo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00816413
Treatments Being Tested
The purpose of this study to find out whether adding trastuzumab and pembro...
Status
Recruiting
Location
Massachusetts General Hospital (Data Collection Only)
Start Date
2024-02-01
Trial ID
NCT06123338